Aarti Drugs (BOM:524348) YoY EPS Growth : 33.79% (As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Aarti Drugs's YoY EPS Growth for the quarter that ended in Mar. 2025 was 33.79%.

Aarti Drugs's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ₹6.81.

Aarti Drugs YoY EPS Growth Historical Data

The historical data trend for Aarti Drugs's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs YoY EPS Growth Chart

Aarti Drugs Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

YoY EPS Growth

Get a 7-Day Free Trial

98.33

-26.41

-18.84

3.28

-1.13

Aarti Drugs Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EPS Growth	Get a 7-Day Free Trial															-15.96	-30.04	-10.72	1.75	33.79

Aarti Drugs YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Aarti Drugs's YoY EPS Growth for the fiscal year that ended in Mar. 2025 is calculated as:

	YoY EPS Growth (A: Mar. 2025 )
=	(Earnings per Share (Diluted) (A: Mar. 2025 )	-	Earnings per Share (Diluted) (A: Mar. 2024 ))	/	\| Earnings per Share (Diluted) (A: Mar. 2024 ) \|
=	(18.35	-	18.56)	/	\| 18.56 \|
=	-1.13 %

Aarti Drugs's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EPS Growth (Q: Mar. 2025 )
=	(Earnings per Share (Diluted) (Q: Mar. 2025 )	-	Earnings per Share (Diluted) (Q: Mar. 2024 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2024 )) \|
=	(6.81	-	5.09)	/	\| 5.09 \|
=	33.79 %

Aarti Drugs YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarti Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » YoY EPS Growth

Traded in Other Exchanges

AARTIDRUGS:India

Address

Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400022

Website

https://www.aartidrugs.co.in

Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.

Aarti Drugs Headlines

No Headlines